Nephrology in Nigeria

Arogundade, Fatiu A.; Esezobor, Christopher; Okafor, Henrietta U.; Abdu, Aliyu; Balogun, Rasheed A.; Effa, Emmanuel; Popoola, Joyce; Bamgboye, Ebun L.

doi:10.1007/978-3-030-56890-0_5

Cited by 3 publications

(15 citation statements)

References 66 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 The number of centers increased from 27 in 2006 1 to 186 reported in 2021 3 , while the dialysis population grew from 300 in 2000 to over 3000 in 2018. 1,3 The average cost of haemodialysis has increased steadily over the years; from N25,000 ($125) in 2005 2 to N36,000-N70,000 ($100-200) in 2018. 3 Dialysate used was mainly acetate, a few centers practiced dialyzer resuse (25%) and no center offered hemodiafiltration treatment in the year 2000.…”

Section: History Of Haemodialysis In Nigeriamentioning

confidence: 99%

“…1,3 The average cost of haemodialysis has increased steadily over the years; from N25,000 ($125) in 2005 2 to N36,000-N70,000 ($100-200) in 2018. 3 Dialysate used was mainly acetate, a few centers practiced dialyzer resuse (25%) and no center offered hemodiafiltration treatment in the year 2000. 3 Femoral catheters were typically used for vascular access in most units as there were few trained experts in central venous catheters insertion and A-V fistulae creation in the year 2000.…”

Section: History Of Haemodialysis In Nigeriamentioning

confidence: 99%

“…3 Dialysate used was mainly acetate, a few centers practiced dialyzer resuse (25%) and no center offered hemodiafiltration treatment in the year 2000. 3 Femoral catheters were typically used for vascular access in most units as there were few trained experts in central venous catheters insertion and A-V fistulae creation in the year 2000. Although trained nephrologist, specialist nurses and dialysis technicians were initially scarce, there has been an increase in the number of nephrologists, dialysis nurses and technicians.…”

Section: History Of Haemodialysis In Nigeriamentioning

confidence: 99%

“…Despite the high prevalence of end stage kidney failure (ESKF) in Nigeria, only 1.5% of these patients receive haemodialysis, which is the most widely available form of renal replacement therapy in Nigeria. [1][2][3] The overarching reason behind this devastatingly low haemodialysis uptake is out-of-pocket payment for health services in the country. [1][2][3] Reports from 2018 revealed that only 3000 patients were receiving haemodialysis nationwide 3 , and 80% of these patients do not sustain treatment beyond three months resulting in repeated hospitalisation of ESKF patients, poor quality of life, high morbidity and premature deaths.…”

Section: Introductionmentioning

confidence: 99%

“…[1][2][3] The overarching reason behind this devastatingly low haemodialysis uptake is out-of-pocket payment for health services in the country. [1][2][3] Reports from 2018 revealed that only 3000 patients were receiving haemodialysis nationwide 3 , and 80% of these patients do not sustain treatment beyond three months resulting in repeated hospitalisation of ESKF patients, poor quality of life, high morbidity and premature deaths. 4 Patient advocacy efforts by nephrology healthcare professionals under the auspices of Nigeria Association of Nephrology has not yielded significant government response.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Global Dialysis Perspective: Nigeria

Okoye

Mamven

2022

Kidney360

View full text Add to dashboard Cite

show abstract

Section: History Of Haemodialysis In Nigeriamentioning

confidence: 99%

Section: History Of Haemodialysis In Nigeriamentioning

confidence: 99%

Section: History Of Haemodialysis In Nigeriamentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Global Dialysis Perspective: Nigeria

Okoye

Mamven

2022

Kidney360

View full text Add to dashboard Cite

show abstract

Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria

Agada-Amade,

Ogbuabor,

Obikeze

et al. 2024

BMC Nephrol

View full text Add to dashboard Cite

Background Evidence of willingness to pay for kidney replacement therapy is scarce in low-middle-income countries, including Nigeria’s Formal Sector Social Health Insurance Programme. The study, therefore, assessed the willingness to pay for haemodialysis among chronic kidney disease patients in Abuja, Nigeria. Methods The study adopted a cross-sectional survey design. We used the contingent valuation method to estimate the maximum stated willingness to pay (WTP) for haemodialysis among end-stage kidney disease (ESKD) patients. We obtained informed written consent from respondents before data collection. The socio-demographic characteristics and willingness to pay data were summarized using descriptive statistics. We evaluated the mean differences in respondents’ WTP using Mann-Whitney and Kruskal-Wallis tests. All variables that had p < 0.25 in the bivariate analysis were included in the Generalized Linear Model (gamma with link function) to determine the predictors of the WTP for one’s and another’s haemodialysis. The level of significance in the final model was ρ < 0.05. Results About 88.3% and 64.8% of ESKD patients were willing to pay for personal and altruistic haemodialysis, correspondingly. The mean annual WTP for haemodialysis for one’s and altruistic haemodialysis was USD25,999.06 and USD 1539.89, respectively. Private hospital patients were likelier to pay for their haemodialysis (β = 0.39, 95%CI: 0.21 to 0.57, p < 0.001). Patients attending public-private partnership hospitals were less likely to pay for altruistic haemodialysis than those attending public hospitals (β = -1.65, 95%CI: -2.51 to -0.79, p < 0.001). Conclusions The willingness to pay for haemodialysis for themselves and others was high. The type of facility ESKD patients attended influenced their willingness to pay for haemodialysis. The findings highlight the need for policies to enhance affordable and equitable access to haemodialysis in Nigeria through pre-payment mechanisms and altruistic financing strategies.

show abstract

Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria

Agada-Amade,

Ogbuabor,

Obikeze

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Evidence of willingness to pay for renal replacement therapy is scarce in low-middle-income countries, including Nigeria's Formal Sector Social Health Insurance Programme. The study, therefore, assessed the willingness to pay for haemodialysis among chronic kidney disease patients in Abuja, Nigeria. Methods The study adopted a cross-sectional survey design. We used the contingent valuation method to estimate the maximum stated willingness to pay (WTP) for haemodialysis among end-stage renal disease (ESRD) patients. The socio-demographic characteristics and willingness to pay data were summarized using descriptive statistics. We evaluated the mean differences in respondents' WTP using Mann-Whitney and Kruskal-Wallis tests. All variables that had p < 0.25 in the bivariate analysis were included in the Generalized Linear Model (gamma with link function) to determine the predictors of the WTP for one's and another's haemodialysis. The level of significance in the final model was ρ < 0.05. Results About 88.3% and 64.8% of patients receiving haemodialysis were willing to pay for their haemodialysis and others, correspondingly. The mean annual WTP for haemodialysis for one’s and altruistic haemodialysis was USD25,999.06 and USD 1539.89, respectively. Private hospital patients were likelier to pay for their haemodialysis (β = 0.39, 95%CI: 0.21 to 0.57, p < 0.001). Patients attending public-private partnership hospitals were less likely to pay for altruistic haemodialysis than those attending public hospitals (β = -1.65, 95%CI: -2.51 to -0.79, p < 0.001). Conclusions The findings highlight the need for policies to promote affordable access to haemodialysis for all socioeconomic groups. Pre-payment mechanisms should be explored rather than out-of-pocket payments which pose financial hardships. The potential for altruistic financing strategies should also inform the redesign of funding policies to enhance equitable access.

show abstract

Nephrology in Nigeria

Cited by 3 publications

References 66 publications

Global Dialysis Perspective: Nigeria

Global Dialysis Perspective: Nigeria

Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria

Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria

Contact Info

Product

Resources

About